Post by Securecell AG

How can cell and gene therapy manufacturing become more measurable, automated, and controllable? The recording of Dr. Mohsen Shaeri’s presentation from Securecell’s Virtual Learn & Connect Seminar is now available to watch on demand. In his talk, Dr. Shaeri, Associate Lead Scientist at Cell and Gene Therapy Catapult, shares practical insights into next-generation automation, Process Analytical Technology (PAT), and Quality by Design (QbD) for advanced therapy manufacturing. The presentation highlights how automated sampling, integrated analytics, centralized data capture, modeling, and feedback control can support better process understanding, reduce variability, and enable more robust and scalable cell and gene therapy processes. Read the article and watch the full recording to learn how connected PAT workflows can help advance the future of cell and gene therapy manufacturing. #CellAndGeneTherapy #CGT #PAT #QualityByDesign #Bioprocessing #Automation #AdvancedTherapies #DigitalBioprocessing